Dr Luke Parkinson is a multidisciplinary scientist with advanced expertise in physical chemistry, bioprocessing, microfluidics, optical technologies and medical devices. He holds a PhD and brings broad capability across experimental design, process development and applied engineering.
Dr Parkinson leads the manufacturing development for the Sementis Copenhagen Vector (SCV) vaccine platform, focusing on translating lab innovation into scalable, regulator‑ready manufacturing processes. He has been key in setting up and operating SCV manufacturing within Adelaide University laboratories, enabling controlled production of viral vectors for preclinical development.
He has helped establish reproducible laboratory manufacturing workflows, underpinning Sementis’ progress toward clinical readiness for SCV-based vaccines.
Combining engineering and biological insight, Dr Parkinson advances SCV‑PHAV and the broader SCV pipeline, ensuring vaccine candidates are designed for performance, manufacturability, and future scale-up.
Career
- Business Development Manager for League Engineering Services Pty Ltd
- Microfluidics Engineer for University of South Australia / Australian National Fabrication Facility Ltd - SA Node
- Research Fellow at Flinders University
- Senior Research Fellow at University of South Australia / Sementis Ltd
Education
- BSc in Physiology / Pharmacology from The University of Adelaide
- BSc(Hons) in Physiology from The University of Queensland
- PhD in Applied Science, Minerals, and Materials from University of South Australia